Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22093187

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2012 Jan 7
First author
Smith MR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2012 Jan 7;379(9810):4-6. doi: 10.1016/S0140-6736(11)61540-7.
    note
    Source null
    related pmid
    22093188
    relationship
    Comment in
  2. citation
    Nat Rev Urol. 2011 Dec 27;9(1):1. doi: 10.1038/nrurol.2011.196.
    note
    Source null
    related pmid
    22200817
    relationship
    Comment in
  3. citation
    J Urol. 2012 Jun;187(6):2098. doi: 10.1016/j.juro.2012.03.041.
    note
    Source null
    related pmid
    22579177
    relationship
    Comment in
  4. citation
    Lancet. 2012 May 12;379(9828):e50; author reply e50-1. doi: 10.1016/S0140-6736(12)60764-8.
    note
    Source null
    related pmid
    22579323
    relationship
    Comment in
  5. citation
    Urol Oncol. 2012 Sep;30(5):747. doi: 10.1016/j.urolonc.2012.06.008.
    note
    Source null
    related pmid
    23021561
    relationship
    Comment in

Authors and identifiers

  1. name
    Smith MR
    type
    Author
  2. name
    Saad F
    type
    Author
  3. name
    Coleman R
    type
    Author
  4. name
    Shore N
    type
    Author
  5. name
    Fizazi K
    type
    Author
  6. name
    Tombal B
    type
    Author
  7. name
    Miller K
    type
    Author
  8. name
    Sieber P
    type
    Author
  9. name
    Karsh L
    type
    Author
  10. name
    Damião R
    type
    Author
  11. name
    Tammela TL
    type
    Author
  12. name
    Egerdie B
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Smith MR
    type
    Author
  2. name
    Saad F
    type
    Author
  3. name
    Coleman R
    type
    Author
  4. name
    Shore N
    type
    Author
  5. name
    Fizazi K
    type
    Author
  6. name
    Tombal B
    type
    Author
  7. name
    Miller K
    type
    Author
  8. name
    Sieber P
    type
    Author
  9. name
    Karsh L
    type
    Author
  10. name
    Damião R
    type
    Author
  11. name
    Tammela TL
    type
    Author
  12. name
    Egerdie B
    type
    Author
bibliography ids
  1. nci-bib-9c246d211c2a87e9661ef7e6
book metadata
content sha256
67c8f760242478194b6739a85f58fc4bd33cac6a5e19c3d79aa08698376c1792
document type
citation
dois
  1. 10.1016/S0140-6736(11)61226-9
electronic publication date
display
2011 Nov 15
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:22093187
immutable id
pubmed:22093187@67c8f760242478194b6739a85f58fc4bd33cac6a5e19c3d79aa08698376c1792
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9810
name
Lancet (London, England)
nlm unique id
2985213R
pages
39-46
volume
379
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2012 Jan 7;379(9810):4-6. doi: 10.1016/S0140-6736(11)61540-7.
    note
    Source null
    related pmid
    22093188
    relationship
    Comment in
  2. citation
    Nat Rev Urol. 2011 Dec 27;9(1):1. doi: 10.1038/nrurol.2011.196.
    note
    Source null
    related pmid
    22200817
    relationship
    Comment in
  3. citation
    J Urol. 2012 Jun;187(6):2098. doi: 10.1016/j.juro.2012.03.041.
    note
    Source null
    related pmid
    22579177
    relationship
    Comment in
  4. citation
    Lancet. 2012 May 12;379(9828):e50; author reply e50-1. doi: 10.1016/S0140-6736(12)60764-8.
    note
    Source null
    related pmid
    22579323
    relationship
    Comment in
  5. citation
    Urol Oncol. 2012 Sep;30(5):747. doi: 10.1016/j.urolonc.2012.06.008.
    note
    Source null
    related pmid
    23021561
    relationship
    Comment in
outcomes validated
false
pmid
22093187
provenance
batch id
b6284687e167e7da9556
provider
NCBI PubMed ESummary
record sha256
fe4148946a606ca8a9b6a2c3320568f2c6a305bb26a93d29c63c7560efc7d23d
response sha256
64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
retrieved at
2026-09-09T23:46:45.216259+00:00
publication date
display
2012 Jan 7
precision
day
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22093187/
title
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.

Preserved source evidence · Not medical advice